Hospira

Hospira to acquire API manufacturing and R&D facilities in India

Thursday, August 30, 2012 11:22 AM

Hospira, a global provider of injectable drugs and infusion technologies, has agreed to acquire an active pharmaceutical ingredient (API) manufacturing facility, together with an associated R&D facility, from Orchid Chemicals & Pharmaceuticals of India for approximately $200 million.

More... »


Hospira to expand operations, create 200 jobs

Wednesday, August 29, 2012 11:20 AM

Hospira, a provider of injectable medicines and infusion technologies, is modernizing and expanding the capabilities of its operations in Nash County of N.C.

More... »


Hospira names Dempsey to board of directors

Thursday, August 18, 2011 01:16 PM

Hospira has named William G. Dempsey to its board of directors. The addition of Dempsey expands Hospira's board to 11 directors, nine of whom are independent.

More... »

FDA approves generic Taxotere

Friday, March 11, 2011 01:47 PM

Hospira has won approval for the first U.S. generic version of Sanofi-aventis’ Taxotere cancer drug, according to a Reuters report.

More... »

Allergen executive takes CEO reins at Hospira

Wednesday, March 9, 2011 01:49 PM

Hospira has named former Allergan President F. Michael Ball its new CEO. The specialty pharma's current chief and founder, Christopher Begley, will become executive chairman.

More... »


CLINICAL TRIAL RESOURCES

Search:

NEWS ONLINE ARCHIVE

Browse by:

CWWeekly

December 17

Medici Global says its Alzheimer's Facebook page demonstrates the need for more early detection trials

Analysts: Expect more equity purchases of CROs in 2013

Already a subscriber?
Log in to your digital subscription.

Subscribe to CWWeekly.

The CenterWatch Monthly

January 2013

Parexel celebrates 30 years of change, growth
CRO's founder and chairman reflects on challenges of the past, present and future

Strategies for increasing patient diversity in trials
Sponsors look to improve racial, ethnic recruitment without going overseas

Already a subscriber?
Log in to your digital subscription.

Purchase the January issue.

Subscribe to The CenterWatch Monthly.

December 2012

Publicity, regulation tightening reins on use of KOLs
Debate rages over need to revamp how sponsors use, pay medical experts

Time may be right to makeover the investigator brochure
Size, complexity prevent critical document from being thoroughly read

Already a subscriber?
Log in to your digital subscription.

Purchase the December issue.

Subscribe to The CenterWatch Monthly.

JobWatch centerwatch.com/jobwatch

Featured Jobs